Breakthrough new digital therapeutic treatment for amblyopia (lazy eye) using virtual reality to replace the dreaded eye patch.
Project Overview
Launched out of Harvard, Luminopia developed a digital therapeutic device for the treatment of amblyopia, more commonly known as lazy eye. The platform utilizes a virtual reality headset to modify popular TV shows and movies into therapeutic visual output. Images taken from this popular content is rebalanced between the eyes to encourage additional usage from the weaker eye and proper binocular fusion.
Boston Children’s partnered with Luminopia to bring increased clinical rigor to the platform and co-develop other virtual and augmented reality treatments for medical conditions.
As of today, Luminopia is being tested in a nationwide Phase 3 trial across 20 clinical sites. The team has partnered with leading media companies such as Sesame Workshop, Nickelodeon, PBS & Dreamworks to optimize the product user experience.
Healthcare Context
Lazy eye affects over 15 million Americans with nearly 100,000 patients born with the disease each year. Current treatment methods require the use of an eye patch daily for two years, which leads to children feeling stigmatized and poor treatment adherence.
Interested in learning more about Luminopia?
Send IDHA an email at accelerator@childrens.harvard.edu